New hepatitis B vaccine formulated with an improved adjuvant system.

@article{Kundi2007NewHB,
  title={New hepatitis B vaccine formulated with an improved adjuvant system.},
  author={Michael Kundi},
  journal={Expert review of vaccines},
  year={2007},
  volume={6 2},
  pages={133-40}
}
A new hepatitis B vaccine (FENDrix, GlaxoSmithKline Biologicals) containing as active substance 20 microg of recombinant hepatitis B virus surface antigen produced in Saccharomyces cerevisiae has recently been licensed in Europe. It is prepared with a novel adjuvant system: aluminum phosphate and 3-O-desacyl-4 -monophosphoryl lipid A. It is intended for use in adults from the age of 15 years onwards for active immunization against hepatitis B virus infection for patients with renal… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 54 extracted citations

From discovery to licensure, the Adjuvant System story

Human vaccines & immunotherapeutics • 2017
View 1 Excerpt

Similar Papers

Loading similar papers…